March 2019 – Bariatric News

Good news, Keto fans!

Source: Eating Fat Won’t Actually Make You Fat, New Reports Claim—And We Are Thrilled

Unequal rates of postoperative complications in relatively healthy bariatric surgical patients of White and Black race. April 19, 2021

Racial disparities in post-surgical complications are often presumed to be due to higher preoperative comorbidity burden among patients of Black race, although being relatively healthy is not a prerequisite for a complication-free postoperative course.

Olubukola O. Nafiu, Christian Mpody, Marc P. Michalsky, Joseph D. Tobias

Sleeve Gastrectomy vs. Roux-En-Y Gastric Bypass in Patients 65 Years of Age and Older: A Comparison of Short-term Outcomes April 17, 2021

Academic Hospital, United States

Joel S. Frieder, Lisandro Montorfano, Camila Ortiz Gomez, Rene Aleman, Luis Felipe Okida, Francisco Ferri, David Romero Funes, Emanuele Lo Menzo, Samuel Szomstein, Raul J. Rosenthal

The Effects of Bariatric Surgery on Dyslipidemia and Insulin Resistance in Overweight Patients With or Without Type 2 Diabetes: a Systematic Review and Network Meta-Analysis April 13, 2021

Obesity has become an epidemic in several regions of the world; it may lead to cardiovascular diseases, diabetes, and dyslipidemia. Despite many therapies, including lifestyle and medical interventions and various surgical options, all bariatric procedures fail in some patients. There is a lack of literature comparing the effects of treatments on specific metabolic indexes.

De-feng Liu, Zheng-ye Ma, Cai-shun Zhang, Qian Lin, Man-wen Li, Kai-zhen Su, Yan-run Li, Hai-dan Wang, Qing Zang, Jing Dong

Preoperative chronic opioid use and its impact on early complications in bariatric surgery: A Swedish nationwide cohort study of 56,183 patients April 13, 2021

The association between severe obesity and chronic pain makes opioid use common among bariatric patients. Preoperative opioid use has been identified as a risk factor in other surgical procedures.

Martin L. Skogar, Magnus Sundbom

Long versus short biliopancreatic limb in Roux-en-Y gastric bypass: short-term results of a randomized clinical trial. April 8, 2021

The Roux-en-Y gastric bypass continues to be one of the most performed bariatric surgeries, since an adequate balance between outcomes, complications and durability have been observed. Recently, the role of the biliopancreatic limb on weight loss and comorbidities control has gained attention, since it seems that has a positive impact based on the length.

Carlos Zerrweck, Antonio Herrera, Elisa M. Sepúlveda, Fátima M. Rodríguez, Lizbeth Guilbert